(Approval lapsed) Cisatracurium 10mg/5mL (2mg/mL) solution for injection/infusion 5mL ampoules (Kalcex)
Section 19A approved medicine
(Approval lapsed) Cisatracurium 10mg/5mL (2mg/mL) solution for injection/infusion 5mL ampoules (Kalcex)
Section 19A approval holder
Juno Pharmaceuticals Pty Ltd ABN 55 156 303 650
Phone
03 8888 1288
Approved until
Status
Expired
Medicines in short supply/unavailable
CISATRACURIUM JUNO Cisatracurium besilate 5mg/2.5mL Solution for Injection ampoule - AUSTR 226854 - anticipated
CISATRACURIUM JUNO cisatracurium (as besilate) 10mg/5mL Solution for Injection ampoule - AUSTR 226857 - anticipated
CISATRACURIUM JUNO cisatracurium (as besilate) 10mg/5mL Solution for Injection ampoule - AUSTR 226857 - anticipated
Indication(s)
Cisatracurium is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation.It is used as an adjunct to general naesthesia, or sedation in the intensive care unit.